Cargando…
Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mayo Foundation for Medical Education and Research
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934659/ https://www.ncbi.nlm.nih.gov/pubmed/33958065 http://dx.doi.org/10.1016/j.mayocp.2021.03.001 |
| _version_ | 1783660857410977792 |
|---|---|
| author | Kow, Chia Siang Abdul Sattar Burud, Ismail Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Abdul Sattar Burud, Ismail Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7934659 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Mayo Foundation for Medical Education and Research |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79346592021-03-05 Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis Kow, Chia Siang Abdul Sattar Burud, Ismail Hasan, Syed Shahzad Mayo Clin Proc Letter to the Editor Mayo Foundation for Medical Education and Research 2021-05 2021-03-05 /pmc/articles/PMC7934659/ /pubmed/33958065 http://dx.doi.org/10.1016/j.mayocp.2021.03.001 Text en © 2021 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Abdul Sattar Burud, Ismail Hasan, Syed Shahzad Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title | Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title_full | Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title_fullStr | Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title_full_unstemmed | Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title_short | Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis |
| title_sort | use of famotidine and risk of severe course of illness in patients with covid-19: a meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934659/ https://www.ncbi.nlm.nih.gov/pubmed/33958065 http://dx.doi.org/10.1016/j.mayocp.2021.03.001 |
| work_keys_str_mv | AT kowchiasiang useoffamotidineandriskofseverecourseofillnessinpatientswithcovid19ametaanalysis AT abdulsattarburudismail useoffamotidineandriskofseverecourseofillnessinpatientswithcovid19ametaanalysis AT hasansyedshahzad useoffamotidineandriskofseverecourseofillnessinpatientswithcovid19ametaanalysis |